Waterloo-Cedar Falls Courier
June is Pride Month, and according to SAGE (Services & Advocacy for GLBT Elders) there are around 3 million LGBTQ seniors 65+ living in the United States. The discrimination that LGBTQ seniors have faced both socially and legally over their lifetimes has taken a toll on their health and well-being.
Sen. Tammy Duckworth (D-Ill.), opinion contributor
Every time I hear a constituent struggling to afford next month’s medications, wondering whether they’ll have to choose between paying for a lifesaving prescription and paying rent, the same question — the same frustration — rushes through my mind.
Continue reading “Senator Duckworth: Senate must pass bill to enable the government to negotiate lower prescription drug prices”
Progressives pushing Congress and President Joe Biden to enact drug pricing reforms that lower costs applauded a two-page principles document published Tuesday by Senate Finance Committee Chair Ron Wyden.
“It’s time for Congress to hold Big Pharma accountable for price-gouging at the pharmacy counter.”
Continue reading “Common Dreams: Key Senate Democrat Applauded for Manifesto on Reducing Drug Costs”
By Annemarie Gibson, a mother of two children 13 and 11 years old living with Type 1 diabetes. She lives in Mira Mesa.
As the mom of two children with Type 1 diabetes, I constantly worry: What if my husband and I lose our health coverage or can no longer afford the medicines they need because drug corporations raise the prices beyond our means?Our sons,
Continue reading “San Diego Union-Tribune: Congress should support the Lower Drug Costs Now Act for affordable medicine”
Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on the Senate Finance Committee’s Principles for Drug Pricing Reform:
“The principles for drug pricing reform released by the Senate Finance Committee are a big step in the right direction and demonstrate that Chairman Wyden plans to prioritize patients,
Continue reading “Senate Finance drug reform principles are an important step. Now we need action.”
The hefty price tag for Biogen’s new Alzheimer’s drug proves that when drug corporations have monopoly power to set prices, they will set them ridiculously high. Biogen is selling false hopes, rather than clinical results, to desperate families — but still stands to make a profit. Already since the announcement of the FDA’s approval, Biogen’s share price has skyrocketed.
By Emily Ingwersen, Special to the Press Herald
Thousands of Mainers and millions of Americans recently filed taxes. As a small-business owner, I probably think more about taxes than the average Mainer, and every tax day I find myself reflecting on all the important investments that taxes make possible in our communities.
Continue reading “Portland Press Herald Commentary: Congress should stop rewarding Big Pharma with tax breaks for gouging patients”